摘要 |
An association of deoxyfructosazine (2-((1R,2S,3R)(1,2,3,4-tetrahydroxybutyl)-5-(2'S,3'R)(2',3',4'-trihydr oxybutyl pyrazine)) (I) and a sulfonyl urea antidiabetic agent (II) is new. Independent claims are also included for: (1) pharmaceutical compositions containing (I); and (2) their use in the prevention and/or treatment of type 2 diabetes and its complications.
|